THINK Surgical

THINK Surgical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $234M

Overview

THINK Surgical is a pioneer in orthopedic robotics, having been founded in 2000. The company's flagship product, the TSolution One® Total Knee Application, combines 3D pre-operative planning software (TCAT®) with an open-platform robotic execution system (TCure®). This approach allows surgeons to create a personalized surgical plan pre-operatively, which is then executed with robotic precision. As a private company, it operates in the competitive but high-growth market of robotic-assisted orthopedic surgery, leveraging AI and machine learning to differentiate its platform.

Orthopedics

Technology Platform

The TSolution One® platform integrates AI-driven pre-operative planning software (TCAT®) with an active, open-architecture robotic surgical system (TCure®) for precise bone preparation in joint replacement surgeries.

Funding History

2
Total raised:$234M
Series B$100M
Series A$134M

Opportunities

The large and growing global market for joint replacement, combined with accelerating adoption of robotic surgery, presents a major expansion opportunity.
The company's open-platform strategy appeals to cost-conscious hospital systems seeking robotic capabilities without being tied to a single implant vendor, creating a distinct market niche.
Further integration of advanced AI for predictive planning and outcomes could deliver a significant competitive edge.

Risk Factors

Intense competition from larger, well-established rivals with integrated implant-robot systems and substantial sales forces poses a major threat to market penetration.
The high capital cost of robotic systems and the need to prove a compelling return on investment can slow hospital adoption rates.
Regulatory delays or setbacks in obtaining clearance for new applications, such as total hip arthroplasty, could hinder growth and product portfolio expansion.

Competitive Landscape

THINK Surgical competes in the active robotic surgery segment for orthopedics against dominant players like Stryker (Mako), Zimmer Biomet (ROSA), and Johnson & Johnson (VELYS). These competitors typically offer closed, proprietary platforms tied to their own implant portfolios. THINK's primary differentiation is its open-platform architecture and its strong emphasis on AI-assisted pre-operative planning, aiming to offer greater surgeon flexibility and data-driven precision.